Amy McMillan

Amy McMillan

Auto-generated profile, based on publicly available information

Amy McMillan

Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, 268 Grosvenor Street, London, ON N6A 4V2 Canada ; Department of Microbiology and Immunology, The University of Western Ontario, London, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2014 in Microbiome
Verified
Journal Article
Open access
PDF file
CUCamilla Urbaniak
Camilla Urbaniak
AMAmy McMillan
Amy McMillan
MAMichelle Angelini
Michelle Angelini
GGGregory B Gloor
Gregory B Gloor
MSMark W Sumarah
Mark W Sumarah
GRGregor Reid
Gregor Reid
Human milk is an important source of bacteria for the developing infant and has been shown to influence the bacterial composition of the neonatal gut, which in turn can affect disease risk later in life. Human milk is also an important source of nutrients, influencing bacterial composition but also directly affecting the host. While recent studies have emphasized the adverse effects of antibiotic therapy on the infant microbiota, the effects of maternal chemotherapy have not been previously studied. Here we report the effects of drug administration on the microbiota and metabolome of human milk.

6 September 2016 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
AMA. McMillan
A. McMillan
JRJustin B Renaud
Justin B Renaud
GGG. B. Gloor
G. B. Gloor
GRGregor Reid
Gregor Reid
MSMark W Sumarah
Mark W Sumarah
Liquid chromatography-high resolution mass spectrometry (LC-MS) has emerged as one of the most widely used platforms for untargeted metabolomics due to its unparalleled sensitivity and metabolite coverage. Despite its prevalence of use, the proportion of true metabolites identified in a given experiment compared to background contaminants and ionization-generated artefacts remains poorly understood. Salt clusters are well documented artefacts of electrospray ionization MS, recognized by their characteristically high mass defects (for this work simply generalized as the decimal numbers after the nominal mass). Exploiting this property, we developed a method to identify and remove salt clusters from LC-MS-based human metabolomics data using mass defect filtering. By comparing the complete set of endogenous metabolites in the human metabolome database to actual plasma, urine and stool samples, we demonstrate that up to 28.5 % of detected features are likely salt clusters. These clusters occur irrespective of ionization mode, column type, sweep gas and sample type, but can be easily removed post-acquisition using a set of R functions presented here. Our mass defect filter removes unwanted noise from LC-MS metabolomics datasets, while retaining true metabolites, and requires only a list of m/z and retention time values. Reducing the number of features prior to statistical analyses will result in more accurate multivariate modeling and differential feature selection, as well as decreased reporting of unknowns that often constitute the largest proportion of human metabolomics data.

16 April 2014 in Microbiome
Verified
Journal Article
Open access
PDF file
GRGregor Reid
Gregor Reid
NNNicholas Nduti
Nicholas Nduti
WSWilbert Sybesma
Wilbert Sybesma
RKRemco Kort
Remco Kort
TKTobias R. Kollmann
Tobias R. Kollmann
SKSteve J Kemp
Steve J Kemp
To augment capacity-building for microbiome and probiotic research in Africa, a workshop was held in Nairobi, Kenya, at which researchers discussed human, animal, insect, and agricultural microbiome and probiotics/prebiotics topics. Five recommendations were made to promote future basic and translational research that benefits Africans.